SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

2021186 citationsJournal Articlegold Open Access

Authors

Laith J. Abu‐Raddad · Cornell University

Hiam Chemaitelly · Weill Cornell Medical College in Qatar

Peter Coyle · Hamad Medical Corporation

Joel A. Malek · Weill Cornell Medical College in Qatar

Ayeda A. Ahmed · Weill Cornell Medical College in Qatar

Yasmin A. Mohamoud · Weill Cornell Medical College in Qatar

Shameem Younuskunju

Abstract

Biomedical Research Program, the Biostatistics, Epidemiology, and Biomathematics Research Core, and the Genomics Core, all at Weill Cornell Medicine-Qatar, the Ministry of Public Health, Hamad Medical Corporation, and the Qatar Genome Programme.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research SARS-CoV-2 detection and testing COVID-19 Clinical Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: EClinicalMedicine

Volume 35, pp. 100861-100861

DOI: 10.1016/j.eclinm.2021.100861

Field-Weighted Citation Impact: 11.71